Home / Research / Product codes / JWY Medical-device intelligence
JWY: Manual Antimicrobial Susceptibility Test Systems FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code JWY
FDA device name Manual Antimicrobial Susceptibility Test Systems
Device class 2
Regulation number 866.1640
Medical specialty Microbiology
Review panel MI The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.
Explore microbiology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 1 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 2 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 519 matching records Device / record Company in FDA record Source Source date Liofilchem MIC Test Strip (MTS), Azithromycin 0.016 - 256 µg/mL K180339 · JWYLiofilchem s.r.l. 510(k) Apr 4, 2018FDA decision date Liofilchem MIC Test Strip (MTS)- Linezolid 0.016 - 256ug/mL K180330 · JWYLiofilchem s.r.l. 510(k) Mar 15, 2018FDA decision date Liofilchem MIC Test Strip (MTS), Ceftazidime-avibactam 0.016/4 - 256/4 µg/mL K173817 · JWYLiofilchem s.r.l. 510(k) Feb 28, 2018FDA decision date Liofilchem MIC Test Strip (MTS), Meropenem/vaborbactam 0.016/8 - 256/8 µg/mL K173307 · JWYLiofilchem s.r.l. 510(k) Dec 19, 2017FDA decision date ETEST OXACILLIN OX 256 US F100
In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spe… Z-0264-2018 · JWYBioMerieux SA Recall Dec 19, 2017FDA classification date ETEST OXACILLIN OX 256 WW F100
In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spec… Z-0265-2018 · JWYBioMerieux SA Recall Dec 19, 2017FDA classification date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Meropenem/Vaborbactam in the Dilution Range of 0.008/8 - 18/8 ug/mL K173209 · JWYThermo Fisher Scientific 510(k) Dec 1, 2017FDA decision date Liofilchem MIC Test Strip (MTS)- Tedizolid 0.002 - 32 mg/mL. K172542 · JWYLiofilchem s.r.l. 510(k) Oct 23, 2017FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.004-8 ug/mL K172454 · JWYThermo Fisher Scientific 510(k) Oct 13, 2017FDA decision date Liofilchem MIC Test Strip (MTS), Erythromycin 0.016 - 256 µg/mL K172109 · JWYLiofilchem s.r.l. 510(k) Sep 27, 2017FDA decision date Etest Ceftazidime/Avibactam (CZA) (0.016 - 256 ug/mL) K172150 · JWYbioMerieux, Inc. 510(k) Sep 15, 2017FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the diluti… K172274 · JWYThermo Fisher Scientific 510(k) Aug 30, 2017FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.0005 8 ug/mL K171870 · JWYThermo Fisher Scientific 510(k) Aug 1, 2017FDA decision date Liofilchem MIC Test Strip (MTS)- Delafloxacin 0.002 - 32 µg/mL K171906 · JWYLiofilchem s.r.l. 510(k) Aug 1, 2017FDA decision date Liofilchem MIC Test Strip (MTS)- Clindamycin 0.016 - 256 µg/mL K170772 · JWYLiofilchem s.r.l. 510(k) Jun 7, 2017FDA decision date Etest Ceftolozane/ Tazobactam (0.016-256 ug/ml) K170670 · JWYbioMerieux, Inc. 510(k) May 31, 2017FDA decision date Liofilchem MIC Test Strip (MTS)- Tedizolid 0.002 - 32 µg/mL K170892 · JWYLiofilchem s.r.l. 510(k) May 25, 2017FDA decision date ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging
ETEST is a quantitative technique for determining the antimicrobial susceptibility… Z-2095-2017 · JWYBioMerieux SA Recall May 3, 2017FDA classification date Ceftriaxone TX 32 US S30, Ref 412302 and Ceftriaxone TX 32 US F100, Ref 507058
ETEST is a quantitative technique for determining the antimicro… Z-2126-2017 · JWYBioMerieux SA Recall May 3, 2017FDA classification date ETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256.
ETEST is a quantitative technique for determining the antim… Z-1521-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Cephalotin CE 256 Foam packaging, Product Name: ETEST Cephalothin CE 0.016-256.
ETEST is a quantitative technique for determining the antim… Z-1522-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Ceftriaxone TXL32 SPB, Product Name: ETEST Ceftriaxone TX 0.002-32(low).
ETEST is a quantitative technique for determining the antimicrobia… Z-1523-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date Ciprofloxacin CI 32 Foam packaging, Product Name: ETEST Ciprofloxacin CI 0.002-32.
ETEST is a quantitative technique for determining the antimicr… Z-1524-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Vancomycin VA 256 FOAM packaging, Product Name: ETEST Vancomycin VA 0.016-256.
ETEST is a quantitative technique for determining the antimi… Z-1525-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Doripenem DOR32 FOAM packaging, Product Name: Etest Doripenem DOR 0.002-32.
ETEST is a quantitative technique for determining the antimicr… Z-1526-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗